moxisylyte has been researched along with Hypertension, Pulmonary in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cottrell, AJ | 1 |
| Pearson, DT | 1 |
| Hunter, S | 1 |
1 other study available for moxisylyte and Hypertension, Pulmonary
| Article | Year |
|---|---|
Alpha blockade in pulmonary hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Child; Humans; Hypertension, Pulmonary; Moxisylyte; Pulmona | 1982 |